M&A
confidence high
sentiment neutral
materiality 0.70
Renovaro Extends LOI with Predictive Oncology, Acquires Shares for $500,000
Lunai Bioworks Inc.
- Renovaro and Predictive Oncology extended the LOI termination date from February 28, 2025 to March 31, 2025.
- Renovaro acquired 467,290 shares of Predictive Oncology common stock for $500,000 at $1.07 per share.
- Renovaro agreed to purchase an additional 901,298 shares for $964,389 upon execution of a definitive merger agreement.
- The amendment eliminated Renovaro's obligation to acquire certain shares under the original warrant exercise provision.